Clinical Trial of the Pan-Caspase Inhibitor, IDN-6556, in Human Liver Preservation Injury.

PubWeight™: 1.36‹?› | Rank: Top 10%

🔗 View Article (PMID 17227570)

Published in Am J Transplant on January 01, 2007

Authors

E S Baskin-Bey1, K Washburn, S Feng, T Oltersdorf, D Shapiro, Mira Huyghe, L Burgart, M Garrity-Park, F G I van Vilsteren, L K Oliver, C B Rosen, G J Gores

Author Affiliations

1: William J. von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

Articles citing this

Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol (2013) 3.55

Hepatocyte death: a clear and present danger. Physiol Rev (2010) 2.18

Molecular mediators of liver ischemia and reperfusion injury: a brief review. Mol Med (2008) 1.43

Biomarker method validation in anticancer drug development. Br J Pharmacol (2007) 1.41

Ischaemia-reperfusion injury in liver transplantation--from bench to bedside. Nat Rev Gastroenterol Hepatol (2012) 1.39

Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species. Transplant Rev (Orlando) (2012) 1.38

Caspase 3 promotes surviving melanoma tumor cell growth after cytotoxic therapy. J Invest Dermatol (2014) 1.30

Apoptosis as a mechanism for liver disease progression. Semin Liver Dis (2010) 1.21

Molecular mechanisms of hepatic apoptosis. Cell Death Dis (2014) 1.21

Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol (2015) 1.13

Inhibition of apoptosis protects mice from ethanol-mediated acceleration of early markers of CCl4 -induced fibrosis but not steatosis or inflammation. Alcohol Clin Exp Res (2012) 1.10

Apoptosis and necrosis in the liver. Compr Physiol (2013) 1.05

Identification and evaluation of small molecule pan-caspase inhibitors in Huntington's disease models. Chem Biol (2010) 1.02

Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy. J Med Chem (2010) 1.00

Structural basis for executioner caspase recognition of P5 position in substrates. Apoptosis (2008) 0.99

Biomarkers distinguish apoptotic and necrotic cell death during hepatic ischemia/reperfusion injury in mice. Liver Transpl (2014) 0.96

Photoreceptor cell death and rescue in retinal detachment and degenerations. Prog Retin Eye Res (2013) 0.91

Elevated cleaved caspase-3 is associated with shortened overall survival in several cancer types. Int J Clin Exp Pathol (2014) 0.90

Caspases as therapeutic targets. J Cell Mol Med (2008) 0.89

Degradation of βII-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury Conditions. Mol Neurobiol (2014) 0.89

Are protozoan metacaspases potential parasite killers? Parasit Vectors (2011) 0.88

Current protective strategies in liver surgery. World J Gastroenterol (2010) 0.88

The potential for caspases in drug discovery. Curr Opin Drug Discov Devel (2010) 0.86

Joint aging and chondrocyte cell death. Int J Clin Rheumtol (2010) 0.86

The role of anesthetic drugs in liver apoptosis. Hepat Mon (2013) 0.86

RIP kinase-mediated necrosis as an alternative mechanisms of photoreceptor death. Oncotarget (2011) 0.85

The role of innate immunity in donor organ procurement. Semin Immunopathol (2011) 0.83

Caspase inhibitors for the treatment of hepatitis C. Clin Liver Dis (2009) 0.82

Protective effect of caspase inhibition on compression-induced muscle damage. J Physiol (2011) 0.82

Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies. Mol Neurobiol (2013) 0.81

Clamping techniques and protecting strategies in liver surgery. HPB (Oxford) (2009) 0.81

Yeast techniques for modeling drugs targeting Bcl-2 and caspase family members. Cell Death Dis (2013) 0.80

Targeting apoptosis in autoimmune hepatitis. Dig Dis Sci (2014) 0.80

The cellular and molecular mechanisms for neutropenia in Barth syndrome. Eur J Haematol (2011) 0.80

The influence of pharmacological preconditioning with sevoflurane on incidence of early allograft dysfunction in liver transplant recipients. Anesthesiol Res Pract (2012) 0.79

Tyrosine phosphorylation of insulin receptor substrates during ischemia/reperfusion-induced apoptosis in rat liver. Langenbecks Arch Surg (2008) 0.78

Temporal regulation of apoptotic and anti-apoptotic molecules after middle cerebral artery occlusion followed by reperfusion. Mol Neurobiol (2013) 0.77

A systematic review of pharmacological treatment options used to reduce ischemia reperfusion injury in rat liver transplantation. PLoS One (2015) 0.77

Caspase inhibition in liver transplantation: from basic research to clinical studies. HPB (Oxford) (2010) 0.77

Functional genetics-directed identification of novel pharmacological inhibitors of FAS- and TNF-dependent apoptosis that protect mice from acute liver failure. Cell Death Dis (2016) 0.76

Caspase inhibitor therapy synergizes with costimulation blockade to promote indefinite islet allograft survival. Diabetes (2010) 0.76

Salutary effect of pre-treatment with an Nrf2 inducer on ischemia reperfusion injury in the rat liver. Gastroenterol Hepatol (Que) (2014) 0.76

TIFA, an inflammatory signaling adaptor, is tumor suppressive for liver cancer. Oncogenesis (2015) 0.76

Mutations to bid cleavage sites protect hepatocytes from apoptosis after ischemia/reperfusion injury. Transplantation (2007) 0.75

Microcystin-LR induced liver injury in mice and in primary human hepatocytes is caused by oncotic necrosis. Toxicon (2016) 0.75

TRO40303, a mitochondrial-targeted cytoprotective compound, provides protection in hepatitis models. Pharmacol Res Perspect (2015) 0.75

Pre-conditions for eliminating mitochondrial dysfunction and maintaining liver function after hepatic ischaemia reperfusion. J Cell Mol Med (2017) 0.75

Articles by these authors

Concern Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med (2000) 29.03

Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med (1993) 7.29

mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene (2007) 7.02

Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature (1992) 6.51

Biliary tract cancers. N Engl J Med (1999) 6.36

Structural basis for the binding of proline-rich peptides to SH3 domains. Cell (1994) 6.34

Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gbetagamma. Nature (1998) 6.32

IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res (1998) 5.41

Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science (1990) 4.91

Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science (1994) 4.50

The complex and intriguing lives of PIP2 with ion channels and transporters. Sci STKE (2001) 4.45

Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest (2000) 3.58

Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. J Exp Med (1993) 3.48

Patient, center and geographic characteristics of nationally placed livers. Am J Transplant (2012) 3.16

Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci U S A (1988) 2.95

Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol Cell Biol (1999) 2.93

Paternal population history of East Asia: sources, patterns, and microevolutionary processes. Am J Hum Genet (2001) 2.71

Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci U S A (1995) 2.70

A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant (2010) 2.69

Solution structure of the antiapoptotic protein bcl-2. Proc Natl Acad Sci U S A (2001) 2.60

Identification of early proteins of the human papilloma viruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells. EMBO J (1987) 2.56

Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology (1999) 2.56

Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib. Circulation (2001) 2.55

The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant (2008) 2.48

The black esophagus. Am J Gastroenterol (1995) 2.45

Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease. Aliment Pharmacol Ther (2004) 2.38

Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res (2000) 2.38

The role of proteases during apoptosis. FASEB J (1996) 2.35

Apoptosis: a mechanism of acute and chronic liver injury. Gut (2005) 2.33

Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest (1999) 2.32

Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl (2000) 2.27

The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol (2000) 2.25

Cell death by apoptosis: basic concepts and disease relevance for the gastroenterologist. Gastroenterology (1996) 2.23

Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl (2000) 2.23

Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line. Hepatology (1999) 2.20

Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg (1997) 2.13

Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease. J Clin Invest (1966) 2.01

Regulatory intramolecular association in a tyrosine kinase of the Tec family. Nature (1997) 1.95

Decreased interstitial cell of cajal volume in patients with slow-transit constipation. Gastroenterology (2000) 1.95

Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice. Infect Immun (1997) 1.93

Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol (2001) 1.93

Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res (1988) 1.89

Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts. Cell (1989) 1.89

Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection. Am J Transplant (2008) 1.86

Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature (1993) 1.85

Low-back pain in pregnancy. Spine (Phila Pa 1976) (1987) 1.84

Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology (1997) 1.83

Diagnosis of gaucher's disease and niemann-pick disease with small samples of venous blood. Science (1967) 1.78

Bax- and Bak-induced cell death in the fission yeast Schizosaccharomyces pombe. Mol Biol Cell (1997) 1.75

Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2007) 1.75

Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi. Clin Infect Dis (1997) 1.74

Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: interrelationship between the alveolar macrophage and the septal fibroblast. Int J Radiat Oncol Biol Phys (1992) 1.73

The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid. Proc Natl Acad Sci U S A (1989) 1.73

Abrogation of disease development in plants expressing animal antiapoptotic genes. Proc Natl Acad Sci U S A (2001) 1.70

Change involving a viral membrane glycoprotein during morphogenesis of group B arboviruses. Virology (1972) 1.69

Serum-mediated resolution of Lyme arthritis in mice. Lab Invest (1996) 1.68

Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J Clin Invest (1997) 1.67

Immunological and biophysical separation of dengue-2 antigens. J Virol (1971) 1.66

Acquisition and transmission of the agent of human granulocytic ehrlichiosis by Ixodes scapularis ticks. J Clin Microbiol (1998) 1.64

The proteins of Japanese encephalitis virus. Virology (1971) 1.63

Isolation and characterization of glucocerebrosidase from human placental tissue. J Biol Chem (1973) 1.62

Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology (1996) 1.62

Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant (2014) 1.62

Effects of alterations in cellular iron on biosynthesis of the transferrin receptor in K562 cells. Mol Cell Biol (1985) 1.61

Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation. Mayo Clin Proc (1994) 1.59

Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins. J Biol Chem (1997) 1.58

Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism. Transplantation (1999) 1.56

Dynamic challenges inhibiting optimal adoption of kidney paired donation: findings of a consensus conference. Am J Transplant (2013) 1.55

Decreased risk of graft failure with maternal liver transplantation in patients with biliary atresia. Am J Transplant (2011) 1.54

Decreased systolic blood pressure through operant conditioning techniques in patients with essential hypertension. Science (1971) 1.54

Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol (2001) 1.52

Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am J Physiol Gastrointest Liver Physiol (2000) 1.51

Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J (1991) 1.50

Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study. Am J Transplant (2014) 1.50

Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant (2012) 1.50

Drug-induced liver injury: mechanisms and test systems. Hepatology (2001) 1.49

Mitochondria as a source of reactive oxygen species during reductive stress in rat hepatocytes. Am J Physiol (1993) 1.49

Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer? J Hepatol (1997) 1.47

Secretin stimulates exocytosis in isolated bile duct epithelial cells by a cyclic AMP-mediated mechanism. J Biol Chem (1992) 1.47

Liver cell necrosis: cellular mechanisms and clinical implications. Gastroenterology (1995) 1.47

Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology (1992) 1.46

Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. J Clin Invest (1993) 1.46

Cholestasis confers resistance to the rat liver mitochondrial permeability transition. Gastroenterology (1998) 1.46

Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor. Proc Natl Acad Sci U S A (1993) 1.45

Death receptors in liver biology and pathobiology. Hepatology (1999) 1.45

Pathogenesis, diagnosis, and treatment of alcoholic liver disease. Mayo Clin Proc (2001) 1.45

Blood pressure morning surge and hostility. Am J Hypertens (1998) 1.45

Phosphatidylinositol 4,5-bisphosphate induces actin stress-fiber formation and inhibits membrane ruffling in CV1 cells. J Cell Biol (2001) 1.43

Delta 9-tetrahydrocannabivarin (delta 9-THCV) as a marker for the ingestion of cannabis versus Marinol. J Anal Toxicol (1999) 1.43

Orthotopic liver transplantation for preoperative early-stage hepatocellular carcinoma. Mayo Clin Proc (1994) 1.43

Single- and multiple-dose-response relationships of beta-carotene in cystic fibrosis. J Pediatr (1995) 1.43

Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest (1994) 1.42

Negative words on surgical wards result in therapeutic failure of patient-controlled analgesia and further release of cortisol after abdominal surgeries. Minerva Anestesiol (2008) 1.41

Antisera to an amino-terminal peptide detect the amyloid protein precursor of Alzheimer's disease and recognize senile plaques. Biochem Biophys Res Commun (1988) 1.41

The galE gene of Campylobacter jejuni is involved in lipopolysaccharide synthesis and virulence. Infect Immun (2000) 1.41

Daclizumab induction therapy in liver transplant recipients with renal insufficiency. Aliment Pharmacol Ther (2010) 1.40

Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. Gastroenterology (2001) 1.40

Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine. Am J Physiol (1997) 1.40